Author

M. Augustin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:proteomics· 3 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:differential expression· 1 Approach:statistical model· 1

Frequent Co-Authors

F. Klein· 3 shared C. Lehmann· 2 shared F. Dewald· 2 shared H. Gruell· 2 shared K. Vanshylla· 2 shared L. Gieselmann· 2 shared P. Schommers· 2 shared A. Simonis· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

F. Klein

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The unique ORF8 protein from SARS-CoV-2 binds to human dendritic cells and induces a hyper-inflammatory cytokine storm

M. Hamdorf, T. Imhof, B. A. Bailey-Elkin, J. Betz, S. J. Theobald, A. Simonis, V. Di Cristanziano, L. Gieselmann, F. Dewald, C. Lehmann, M. Augustin, F. Klein, M. A. Alcazar, R. Rogisch, M. Fabri, , F. Bock

This study shows that SARS-CoV-2's ORF8 protein binds to human dendritic cells, induces cytokine storms, and may be a target for therapeutic intervention.

bioRxiv · Jun 6, 2022 · PreprintImmunology

Delineating antibody escape from Omicron sublineages

H. Gruell, K. Vanshylla, M. Korenkov, P. Tober-Lau, M. Zehner, F. Muenn, H. Janicki, M. Augustin, P. Schommers, L. E. Sander, F. Kurth, C. Kreer, F. Klein

This study evaluates antibody escape from Omicron sublineages by testing serum and monoclonal antibody activity against BA.1, BA.2, BA.2.12.1, and BA.4/5, revealing increased resistance in BA.4/5 and identifying promising neutralizing antibodies.

bioRxiv · Apr 6, 2022 · PreprintImmunology

Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2

K. Vanshylla, V. Di Cristianziano, F. Kleipass, F. Dewald, P. Schommers, L. Gieselmann, H. Gruell, M. Schlotz, M. S. Ercanoglu, R. Stumpf, P. Mayer, E. Heger, W. Johannis, C. Horn, I. Suarez, , F. Klein

This study examines the kinetics and correlates of the SARS-CoV-2 neutralizing antibody response in 963 recovered individuals over 10 months, finding variations in antibody persistence and identifying factors predicting neutralizing activity.

bioRxiv · Jan 26, 2021 · PreprintImmunology